Cargando…

The relationship between HbA1c and cardiovascular events in diabetic patients with coronary angioplasty: A cross-sectional study

INTRODUCTION: Re-establishment of coronary artery blood flow in diabetic patients has always been a controversial issue in the treatment of cardiovascular diseases. Due to the importance of this issue and the increase in mortality due to heart disease, the present study was performed to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adel, Seyed Mohammad Hassan, Seyedian, Masoud, Nourizadeh, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963624/ https://www.ncbi.nlm.nih.gov/pubmed/35360770 http://dx.doi.org/10.4103/jfmpc.jfmpc_1206_21

Ejemplares similares

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

HbA(1c) measurement and relationship to incident stroke
por: Robson, R., et al.
Publicado: (2016)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2022)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Relationship between level of HbA1C and breast cancer
por: Jousheghany, Fariba, et al.
Publicado: (2016)

HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease
por: Jiao, Xiaojuan, et al.
Publicado: (2023)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)

Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease
por: Seyedian, Seyed Masoud, et al.
Publicado: (2016)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014)

Association of HbA1c Values with Mortality and Cardiovascular Events in Diabetic Dialysis Patients. The INVOR Study and Review of the Literature
por: Sturm, Gisela, et al.
Publicado: (2011)

Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population
por: Hernandez, Domingo, et al.
Publicado: (2013)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

Prevalence of dyslipidemia and the relationship between HbA1C and lipid profile in Moroccan patients with T2DM: a cross-sectional study
por: Alami, Houda El, et al.
Publicado: (2022)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC
por: Agilli, Mehmet, et al.
Publicado: (2013)

Change in HbA(1c) over 3 years does not improve the prediction of cardiovascular disease over and above HbA(1c) measured at a single time point
por: Chamnan, P., et al.
Publicado: (2013)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c
por: Pant, Vivek, et al.
Publicado: (2021)

Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023)

Association and comparison of periodontal and oral hygiene status with serum HbA1c levels: a cross-sectional study
por: Rahim, Abid, et al.
Publicado: (2023)

The relationship between HbA1c & atrial fibrillation after off-pump coronary artery bypass surgery in diabetic patients
por: Surer, Suleyman, et al.
Publicado: (2016)

Differential Thermal Stability and Oxidative Vulnerability of the Hemoglobin Variants, HbA(2) and HbE
por: Chakrabarti, Abhijit, et al.
Publicado: (2013)

Significantly High HbA(1c) in Diabetic Patient with Hb J: Case Report
por: Wan Nik, Wan Nor Fazila Hafizan, et al.
Publicado: (2022)

Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs
por: Norris, Olga, et al.
Publicado: (2022)

The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome
por: Xu, Shaodong, et al.
Publicado: (2022)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

HbA(1c) for Diabetes Screening in Acute Coronary Syndrome: time for a reappraisal of the guidelines?
por: McCune, C, et al.
Publicado: (2015)

Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
por: Kurukulasuriya, L Romayne, et al.
Publicado: (2010)

Association of Low Fasting Glucose and HbA1c With Cardiovascular Disease and Mortality: The MESA Study
por: Mongraw-Chaffin, Morgana, et al.
Publicado: (2019)

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
por: Ali, Amar, et al.
Publicado: (2019)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_40ihj6t8h5v5glka7hcekcrk5q